Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
11070.6000 112.45 (1.03%)
NSE Mar 13, 2025 15:31 PM
Volume: 52,775
 

11070.60
1.03%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Number of MF schemes increased from 10 to 16 in Dec 2024 qtr.
More from Neuland Laboratories Ltd.
Recommended